R Ren, X Wang, Z Xu, W Jiang - Archives of Pharmacal Research, 2023 - Springer
Paritaprevir is a potent inhibitor of the NS3/4A protease used to treat chronic hepatitis C
virus infection. However, its therapeutic effect on acute lung injury (ALI) remains to be …